Back
Nkarta, Inc. NKTX · Insights
Nkarta, Inc., a clinical-stage biopharmaceutical company, develops and commercializes natural killer... Price1.59
Market Cap118.78 M
Float57.13 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscriptsInsights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro